These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25614715)

  • 21. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
    Horiike Y; Suzuki Y; Fujisawa T; Yasui H; Karayama M; Hozumi H; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Ogawa N; Suda T
    Rheumatology (Oxford); 2019 Dec; 58(12):2143-2152. PubMed ID: 31143953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular epidemiology of the hemagglutinin gene of prevalent influenza virus A/H1N1/pdm09 among patient in Iran.
    Mohebbi A; Fotouhi F; Jamali A; Yaghobi R; Farahmand B; Mohebbi R
    Virus Res; 2019 Jan; 259():38-45. PubMed ID: 30336188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Emerged Pdm09 influenza virus increased purifying selection of seasonal H1N1 influenza virus].
    Lan Y; Huang WJ; Sui HT; Li XY; Zhao X; Li M; Chen YY; Guo JF; Cheng YH; Tan MJ; Wang Z; Xiao N; Wei HJ; Wang DY; Shu YL
    Bing Du Xue Bao; 2013 Mar; 29(2):143-7. PubMed ID: 23757844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates.
    Hansen C; Desai S; Bredfeldt C; Cheetham C; Gallagher M; Li DK; Raebel MA; Riedlinger K; Shay DK; Thompson M; Davis RL
    J Infect Dis; 2012 Oct; 206(8):1260-8. PubMed ID: 22859826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oseltamivir-resistant seasonal A(H1N1) and A(H1N1)pdm09 influenza viruses from the 2007/2008 to 2012/2013 season in Nara Prefecture, Japan.
    Yoneda M; Okayama A; Kitahori Y
    Jpn J Infect Dis; 2014; 67(5):385-8. PubMed ID: 25241691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.
    Hillaire MLB; Vogelzang-van Trierum SE; Kreijtz JHCM; de Mutsert G; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
    J Gen Virol; 2013 Mar; 94(Pt 3):583-592. PubMed ID: 23152369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new pandemic influenza A/(H1N1)pdm09 virus: is it really "new"?
    Baldo V; Bertoncello C; Cocchio S; Fonzo M; Pillon P; Buja A; Baldovin T
    J Prev Med Hyg; 2016; 57(1):E19-22. PubMed ID: 27346935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CD206 and CD163 on intermediate CD14
    Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
    Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetic analysis of the Influenza A(H1N1)pdm09 virus from lethal and recovered cases in Russia from 2009 to 2014: Deletions in the nucleoprotein.
    Yatsyshina S; Renteeva A; Deviatkin A; Vorobyeva N; Minenko A; Valdokhina A; Elkina M; Kuleshov K; Shipulin G
    Infect Genet Evol; 2015 Aug; 34():160-72. PubMed ID: 26190451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
    Choreño-Parra JA; Jiménez-Álvarez LA; Ramírez-Martínez G; Sandoval-Vega M; Salinas-Lara C; Sánchez-Garibay C; Luna-Rivero C; Hernández-Montiel EM; Fernández-López LA; Cabrera-Cornejo MF; Choreño-Parra EM; Cruz-Lagunas A; Domínguez A; Márquez-García E; Cabello-Gutiérrez C; Bolaños-Morales FV; Mena-Hernández L; Delgado-Zaldivar D; Rebolledo-García D; Guadarrama-Ortiz P; Regino-Zamarripa NE; Mendoza-Milla C; García-Latorre EA; Rodiguez-Reyna TS; Cervántes-Rosete D; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
    Front Immunol; 2021; 12():633297. PubMed ID: 33717172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
    Haveri A; Ikonen N; Kantele A; Anttila VJ; Ruotsalainen E; Savolainen-Kopra C; Julkunen I
    Vaccine; 2019 May; 37(20):2731-2740. PubMed ID: 30954308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous discrimination and detection of influenza A(H1N1)pdm09 and seasonal influenza A viruses using a rapid immunogold biosensor.
    Apiwat C; Wiriyachaiporn N; Maneeprakorn W; Dharakul T; Thepthai C; Puthavathana P; Siritantikorn S; Horthongkham N
    Arch Virol; 2014 Jul; 159(7):1603-11. PubMed ID: 24402634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of bronchoalveolar lavage fluid in a mouse model of bronchial asthma and H1N1 2009 infection.
    Okada S; Hasegawa S; Hasegawa H; Ainai A; Atsuta R; Ikemoto K; Sasaki K; Toda S; Shirabe K; Takahara M; Harada S; Morishima T; Ichiyama T
    Cytokine; 2013 Aug; 63(2):194-200. PubMed ID: 23706975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.
    Yin JK; Chow MY; Khandaker G; King C; Richmond P; Heron L; Booy R
    Vaccine; 2012 May; 30(21):3209-22. PubMed ID: 22387221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Mortality in Seasonal H3N2 Patients Compared with those with Pandemic 2009 H1N1 in Taiwan, 2009-2010.
    Huang SY; Huang WC; Chen YC; Tsai CY; Lee IK
    Am J Trop Med Hyg; 2017 Dec; 97(6):1945-1951. PubMed ID: 29016325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of influenza in the adult population during seasonal and A(H1N1)pdm09 pandemic influenza periods.
    Gefenaite G; Tacken M; Kolthof J; Mulder B; Korevaar JC; Stirbu-Wagner I; Bos J; Stolk RP; Hak E
    Epidemiol Infect; 2014 May; 142(5):950-4. PubMed ID: 24073672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.
    Jegaskanda S; Laurie KL; Amarasena TH; Winnall WR; Kramski M; De Rose R; Barr IG; Brooks AG; Reading PC; Kent SJ
    J Infect Dis; 2013 Oct; 208(7):1051-61. PubMed ID: 23812238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.